Recent Advances in Cancer Gene Therapy: Probiotic-Derived Postbiotics as a Promising Alternative

A new study published in Frontiers in Nutrition has highlighted the potential of probiotic-derived postbiotics as a sustainable and effective alternative to live microbial therapy in cancer gene therapy. Research from the School of Biosciences and Technology in Vellore, India, has shown that postbiotics, bioactive metabolites produced by probiotics, possess immunomodulatory, antimicrobial, antioxidant, and anti-cancer properties. Despite the promising findings, the study notes that further research is needed to clarify the mechanisms of action, define optimal delivery strategies, and assess long-term safety.

Key Takeaways:

• Probiotic-derived postbiotics are a promising alternative to live microbial therapy in cancer gene therapy, offering a sustainable and effective solution.
• Postbiotics have been shown to possess immunomodulatory, antimicrobial, antioxidant, and anti-cancer properties, making them a valuable therapeutic option.
• The study highlights the importance of clarifying the mechanisms of action, defining optimal delivery strategies, and assessing long-term safety of postbiotics in future research.
• Recent developments in formulation techniques, such as encapsulation, have enhanced the stability and bioavailability of postbiotics.
• The use of postbiotics aligns with global health goals, specifically Sustainable Development 3 (Good Health and Well-being) and Sustainable Development 9 (Industry, Innovation, and Infrastructure).

Statistics:

• The study focuses on key classes of postbiotics, including exopolysaccharides, cell-free supernatants, short-chain fatty acids, and bacteriocins.
• The immunomodulatory, antimicrobial, antioxidant, and anti-cancer properties of postbiotics have been reported in various studies.
• The use of encapsulation has enhanced the stability and bioavailability of postbiotics, making them a more potent therapeutic option.
• The study aims to clarify the mechanisms of action of postbiotics and define optimal delivery strategies, with the goal of assessing long-term safety.

Sources:

• Probiotic-derived postbiotics: a perspective on next-generation therapeutics. Frontiers in Nutrition, 2025,12 (Frontiers in Nutrition - http://www.frontiersin.org/nutrition).
• Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
• Veilumuthu Pattapulavar, Bhagyashree Kini, John Godwin Christopher, and Sathiyabama Ramanujam, Additional authors.